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Abstract
Background: Muscarinic acetylcholine receptors (mAChRs) undergo agonist-promoted
internalization, but evidence suggesting that the mechanism of internalization is β-arrestin
dependent has been contradictory and unclear. Previous studies using heterologous over-
expression of wild type or dominant-negative forms of β-arrestins have reported that agonist-
promoted internalization of M2 mAChRs is a β-arrestin- and clathrin-independent phenomenon. In
order to circumvent the complications associated with the presence of endogenous β-arrestin that
may have existed in these earlier studies, we examined agonist-promoted internalization of the M2
mAChR in mouse embryonic fibroblasts (MEFs) derived from β-arrestin knockout mice that lack
expression of either one or both isoforms of β-arrestin (β-arrestin 1 and 2).
Results: In wild type MEF cells transiently expressing M2 mAChRs, 40% of surface M2 mAChRs
underwent internalization and sorted into intracellular compartments following agonist stimulation.
In contrast, M2 mAChRs failed to undergo internalization and sorting into intracellular
compartments in MEF β-arrestin double knockout cells following agonist stimulation. In double
knockout cells, expression of either β-arrestin 1 or 2 isoforms resulted in rescue of agonist-
promoted internalization. Stimulation of M2 mAChRs led to a stable co-localization with GFP-
tagged β-arrestin within endocytic structures in multiple cell lines; the compartment to which β-
arrestin localized was determined to be the early endosome. Agonist-promoted internalization of
M2 mAChRs was moderately rescued in MEF β-arrestin 1 and 2 double knockout cells expressing
exogenous arrestin mutants that were selectively defective in interactions with clathrin (β-arrestin
2 ΔLIELD), AP-2 (β-arrestin 2-F391A), or both clathrin/AP-2. Expression of a truncated carboxy-
terminal region of β-arrestin 1 (319–418) completely abrogated agonist-promoted internalization
of M2 mAChRs in wild type MEF cells.
Conclusion: In summary, this study demonstrates that agonist-promoted internalization of M2
mAChRs is β-arrestin- and clathrin-dependent, and that the receptor stably co-localizes with β-
arrestin in early endosomal vesicles.
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Muscarinic acetylcholine receptors belong to the super-
family of G-protein coupled receptors (GPCRs) that are
commonly expressed in a variety of tissues and are classi-
fied into five known subtypes (M1 -M5 mAChR). M1, M3,
and M5 mAChRs are selectively coupled to Gq proteins
while M2 and M4 mAChRs are linked to Gi/G0 proteins
[1,2]. M2 mAChRs are the primary muscarinic subtype in
the heart where their stimulation leads to the regulation of
myocardial contractility [3]. As with other GPCRs, M2
mAChR activity is tightly regulated by desensitization and
internalization. These regulatory mechanisms are typi-
cally associated with receptor phosphorylation followed
by either recycling or down-regulation [4-9].
Desensitization is a complex process that involves ago-
nist-dependent phosphorylation at specific serine/threo-
nine residues by G-protein-coupled receptor kinases
(GRKs) followed by β-arrestin binding. Two widely
expressed isoforms of β-arrestin (1 and 2) are known to be
involved in uncoupling receptors from their cognate G-
proteins thereby attenuating receptor signalling [10,11].
Typically, agonist-induced phosphorylation facilitates
receptor internalization, which serves to either resensitize
or down-regulate desensitized receptors [12]. β-arrestins
have been shown to facilitate internalization by directly
interacting with the β2 subunit of the clathrin-AP2 (adap-
tor protein 2) complex and clathrin itself [11,13]. Thus, β-
arrestins can induce receptor sequestration by directly
interacting with the endocytic machinery. Many receptors
such as the prototypic β2-adrenergic receptor (β2AR) inter-
nalize in a clathrin and β-arrestin dependent fashion.
Hence, β-arrestin facilitates clathrin-mediated endocyto-
sis [11,13].
In addition to desensitization and internalization, β-
arrestins are known to play a role in other cellular proc-
esses that include intracellular trafficking and signalling
[12]. Association of β-arrestin with agonist-occupied
receptors has been shown to initiate intracellular signal-
ling by functioning as an assembly site for signalling com-
ponents such as Src, JNK3, and ERK1/2 [14-17].
Therefore, β-arrestin-receptor complexes can lead to
cytosolic retention and activation of signalling molecules
following receptor-mediated signalling at the cell surface.
The physiological roles of this process include decreasing
cell proliferation and regulating cytoskeletal rearrange-
ments by spatially restricting ERK activation to the cytosol
[16,18]. Recent reports have also suggested that β-
arrestins can function at post-endocytic stages to regulate
receptor sorting. It has been shown that receptors exhibit
differential affinities for β-arrestin and therefore are clas-
sified into two groups [19]. Class A receptors (including
β2AR and dopamine receptors) are thought to interact
with β-arrestin at the plasma membrane but immediately
disassociate following localization to clathrin-coated pits.
Hence receptors enter early endosomes devoid of β-arres-
tin and are typically resensitized and rapidly recycled [20].
In contrast, Class B receptors (vasopressin-V2R, angi-
otensin-AT1AR, and neurotensin receptors) stably associ-
ate with β-arrestin so that β-arrestin/receptor complexes
remain intact and are internalized into juxtanuclear endo-
somal compartments [21]. This interaction can persist for
prolonged periods of time. This stable association may
dictate the kinetics of receptor recycling since AT1AR and
V2R recycle very slowly [20,21]. A functional consequence
of β-arrestin association may also be to facilitate receptor
down-regulation.
The role of β-arrestins in regulating the trafficking of M2
mAChRs has been contradictory and unclear. Reports
have demonstrated that phosphorylation by GRK2 on ser-
ine/threonine residues in the third intracellular loop of
M2 mAChRs recruits β-arrestin and leads to receptor
desensitization and subsequent internalization [7].
Whether β-arrestin is involved directly in agonist-pro-
moted endocytosis of M2 mAChRs remains unclear.
Indeed over-expression of β-arrestin has been reported to
increase agonist-promoted internalization of M2 mAChRs
but not of M1 or M3 mAChRs [22]. Furthermore, Claing et
al. have shown that M2 mAChRs internalize in a dynamin-
and β-arrestin-insensitive manner when expressed in
HEK293 cells [23]. Others have reported that the Arf6
GTPase (ADP-ribosylation factor 6) facilitates M2 mAChR
entry into primary vesicles, which fuse with clathrin-
derived early endosomes [24,25]. These data do not nec-
essarily rule out β-arrestin as a regulator in agonist-pro-
moted endocytosis of M2 mAChRs. Therefore, to clarify
whether agonist-promoted internalization of M2 mAChRs
is arrestin dependent, we utilized mouse embryonic
fibroblasts (MEFs) derived from β-arrestin null mice that
lack expression of one or both isoforms (β-arrestin 1 and
2) and their wild type littermates as control cells [26].
Here we report that agonist-promoted internalization of
M2 mAChRs is β-arrestin dependent and M2 mAChRs
form stable complexes with β-arrestin at the early endo-
some. Furthermore, we demonstrate that agonist-pro-
moted internalization of M2 mAChRs is clathrin-
dependent. These results suggest that β-arrestin plays an
important role in regulating M2 mAChR activity.
Results
To determine whether the MEF cells used in this study
expressed endogenous mAChRs, we performed RT-PCR
aimed at detecting mRNA encoding M1, M2 and M4
mAChR subtypes. As positive controls, we used postnatal
rat cerebellum tissue for M2 mAChR mRNA and postnatal
rat cortical tissue for M1 and M4 mAChR mRNA. RT-PCR
analysis clearly demonstrated that MEF wild type as wellPage 2 of 15
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express mRNA encoding M1, M2, or M4 mAChR subtypes
(Fig. 1). Accordingly, radioligand-binding assays also con-
firmed that MEF wild type as well as MEF KO1/2 did not
express mAChRs at any detectable level (data not shown).
Therefore, we concluded that MEF cells do not express
endogenous mAChRs.
To examine whether ectopically expressed M2 mAChRs
undergo agonist-promoted internalization in MEFs, we
transiently transfected MEF wild type and corresponding
β-arrestin null cells with a plasmid encoding a FLAG-
tagged porcine M2 mAChR. Following 24 h transfection,
MEF wild type, MEF KO1, MEF KO2, and MEF KO1/2 cells
were stimulated with 1 mM carbachol for 1 h at 37°C. The
number of receptors remaining at the cell surface was
measured using a saturating concentration of the
hydrophilic ligand [3H]-NMS. Approximately 40% of sur-
face M2 mAChRs were internalized in wild type MEF cells
while M2 mAChRs in MEF KO1 and MEF KO2 cells were
internalized by 33% and 42%, respectively. In contrast,
M2 mAChRs were not internalized in MEF KO1/2 (Fig.
2A). These results demonstrated that exogenously
expressed M2 mAChRs undergo agonist-promoted inter-
nalization in MEF wild type cells and either β-arrestin iso-
form was sufficient for sequestration. To further evaluate
where M2 mAChRs were localized, we used confocal
immunofluorescence microscopy in MEF wild type or
MEF KO1/2 cells transiently expressing a FLAG-tagged M2
mAChR in the absence or presence of carbachol. As indi-
cated in Figure 2B, diffuse cell surface localization of M2
mAChRs was observed prior to carbachol addition in both
MEF phenotypes. Upon addition of agonist, M2 mAChRs
in MEF wild type cells redistributed into discrete intracel-
lular vesicles dispersed throughout the cell while M2
mAChRs expressed in MEF KO1/2 cells remained at the
cell surface (Fig. 2B). The diffuse pattern shown in MEF
KO1/2 cells represents surface plasma membrane locali-
zation since the absence of detergent leads to an identical
staining pattern as seen in untreated cells (data not shown).
Mouse embryonic fibroblasts (MEF) cells do not express mRNA encoding M1, M2 or M4 mAChR subtypesFig re 1
Mouse embryonic fibroblasts (MEF) cells do not express mRNA encoding M1, M2 or M4 mAChR subtypes. A rep-
resentative gel showing lack of mAChR expression in MEF wild type and KO1/2 cells Lanes consisted of 100 bp ladder (lane 1), 
wild type MEF cells (lanes 2, 5, 8 and 11), MEF β-arrestin KO1/2 (lanes 3, 6, 9, and 12), rat cortex (lanes 4 and 10 and 13), and 
rat cerebellum (lane 7). The white arrows point to M1, M2 and M4 mAChR PCR product from cDNA as positive controls. The 
electrophoresis gel shown is a representative of at least 3 independent experiments.Page 3 of 15
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and is accessible to exogenously added antibody even in
the absence of detergent.
To determine whether selectivity existed between β-arres-
tin isoforms in their ability to mediate agonist-promoted
internalization of M2 mAChRs, we examined agonist pro-
Agonist-promoted internalization of M2 mAChR in MEFs is β-arrestin-dependentFigure 2
Agonist-promoted internalization of M2 mAChR in MEFs is β-arrestin-dependent. A.) Approximately 24 h following 
transfection with M2 mAChR, cells were stimulated with 1 mM carbachol for 1 h and agonist-promoted internalization was 
determined using [3H-NMS]. Data are presented as the mean ± standard error from 3 separate experiments with each exper-
iment consisting of 8 to 11 independent determinations. Statistical test was performed using ANOVA with the post hoc Bon-
ferroni/Dunn test (asterisk indicates * p < 0.001). B.) Cells were transfected as described above and then incubated in the 
presence or absence of 1 mM carbachol for 30 minutes prior to indirect immunofluorescence as described in Methods. Images 
were acquired at 40X.Page 4 of 15
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M2 mAChR and FLAG-tagged β-arrestin 1 and/or 2 (Fig.
3A). Western blotting analysis confirmed that FLAG-
tagged β-arrestins were expressed (Fig. 3B). Cells were
treated with 1 mM carbachol for 1 h and the extent of
receptor internalization was assessed using [3H]-NMS.
MEF KO1/2 cells reintroduced with β-arrestin 1, β-arrestin
2, or both isoforms exhibited M2 mAChR uptake similarly
(Fig. 3A). These data suggest that not only is agonist-pro-
moted internalization of M2 mAChR β-arrestin-dependent
but also there is no selectivity between β-arrestin isoforms
(Fig. 2A and 3A). To assess whether stimulated and inter-
nalized M2 mAChRs co-localize with β-arrestin 1 or 2, we
reintroduced GFP-tagged β-arrestin 1, 2, or both isoforms
with FLAG-tagged M2 mAChRs into MEF KO1/2 cells and
assessed their localization by immunofluorescence micro-
scopy. Internalized M2 mAChRs remained associated withβ-arrestin 1-GFP (data not shown) or β-arrestin 2-GFP (Fig.
4) in intracellular compartments following 30 minutes
stimulation with 1 mM carbachol. To determine if this
phenomenon occurs in other cell types we expressed M2
mAChRs in HeLa, COS-7, and rat aortic smooth muscle
cells (RASMCs). As observed in MEF KO1/2 cells, internal-
ized M2 mAChRs remained co-localized with β-arrestin 2-
GFP in HeLa, COS-7, and RASMCs (Fig. 5). These results
demonstrate that agonist-promoted internalization of the
M2 mAChR is β-arrestin-dependent, and that internalized
M2 mAChRs stably associate with either β-arrestin isoform
in multiple cell lines.
Previously, sequestration of M1, M3, and M4 mAChRs
was shown to be both β-arrestin and clathrin-dependent
[23,27]. In contrast M2 mAChR sequestration was
reported to be largely β-arrestin and clathrin-independent
[22,28]. To address whether the β-arrestin-dependent
internalization we observed in MEFs was independent of
clathrin, we expressed in MEF KO1/2 cells arrestin
mutants that were selectively defective in interaction with
clathrin (β-arrestin 2 ΔLIELD), AP-2 (β-arrestin 2-F391A),
or both clathrin/AP-2 (β-arrestin 2 ΔLIELD/F391A) [29].
Expression of either the β-arrestin 2 ΔLIELD or β-arrestin
2-F391A mutant rescued agonist-promoted M2 mAChR
internalization (Fig. 6A). However, internalization was
only moderately rescued by transient expression of a β-
arrestin 2 mutant defective in both clathrin and AP-2
interaction (Fig. 6A). These results indicate that β-arrestin-
dependent internalization of M2 mAChR may include a
component that is independent of interactions between
clathrin and AP-2.
Recent studies by Santini and co-workers [30] showed
that agonist-mediated activation of the β2AR was still
capable of inducing recruitment into clathrin coated pits
in cells expressing mutant arrestin proteins that were
defective in binding with clathrin or AP-2, albeit to a
reduced degree. Expression of the truncated COOH-termi-
nal region of β-arrestin 1 (319–418), which contains a
clathrin binding site but lacks receptor binding, com-
pletely inhibited the β2AR mediated clustering of clathrin
coated pits [31]. Therefore, we conducted experiments
with the truncated β-arrestin 1 (319–418) to determine
whether agonist-promoted internalization of the M2
mAChR in MEFs would be affected. Transient expression
of the truncated β-arrestin 1 (319–418) completely inhib-
ited the agonist-promoted internalization of the M2
mAChR in MEF wild type cells (Fig. 6B). Thus, it could be
argued that the agonist-promoted internalization of M2
mAChR involved a clathrin-dependent pathway. How-
ever, as shown previously, expression of an arrestin 2
mutant that was defective in interaction with both clath-
rin and AP-2 only moderately antagonized the agonist-
promoted internalization of M2 mAChR in MEF KO1/2
cells (Fig. 6A). It could be argued that this arrestin mutant,
defective in clathrin/AP-2 binding, was still capable of
interacting with clathrin/AP-2, albeit to a significantly
reduced degree. Thus, it is reasonable to conclude that the
agonist-promoted internalization of M2 mAChRs was
clathrin-dependent.
Based upon the findings described above, we sought the
identity of the endosomal structures to which β-arrestin
localized following M2 mAChR activation. We performed
co-localization analyses using markers of the early endo-
some, the early endosomal autoantigen-1 (EEA-1) and the
transferrin receptor (TfnR), in combination with β-arres-
tin 1-GFP. β-arrestin 1-GFP and FLAG-M2 mAChRs were
co-expressed in HeLa cells, and cells were stimulated with
1 mM carbachol for 30 minutes. Our results showed that
β-arrestin 1-GFP significantly co-localized with EEA-1 and
TfnR (as indicated by arrows in Fig. 7). β-arrestin 1-GFP
was not observed to be associated with EEA-1 or TfnR in
unstimulated HeLa cells (Fig. 7). These results indicate
that once M2 mAChRs are internalized via a β-arrestin
dependent pathway, they remain co-localized with β-
arrestin in clathrin-derived early endosomes. To address
whether other muscarinic receptor subtypes stably associ-
ate with β-arrestin in endosomes, we co-expressed HA-
tagged M1, M3, M4, and M5 mAChRs with β-arrestin 2-GFP
in MEF wild type cells and assessed β-arrestin localization
using confocal microscopy (Fig. 8). The upper right inset
in each frame of the figure shows the localization of the
muscarinic receptor subtype for a small section of the cell
co-expressing β-arrestin 2-GFP. Overlay images indicate
co-immunostaining of mAChRs (red) with β-arrestin 2-
GFP (green) and their extent of co-localization (yellow).
In the absence of carbachol, β-arrestin 2-GFP was diffusely
localized in the cytosol of cells expressing M1 – M5
mAChR subtypes (Fig. 8, 0 min). Following 30 minute
carbachol stimulation only cells expressing human FLAG-
tagged M2 mAChRs exhibited β-arrestin 2-GFP localiza-Page 5 of 15
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indicating overlap and corresponding overlay image (Fig.
8, 30 min); in cells expressing other receptor subtypes, β-
arrestin 2-GFP remained diffusely distributed. Hence,
only cells expressing the FLAG-tagged M2 mAChR subtype
exhibited a stable interaction with β-arrestin at intracellu-
lar sites compared to the other muscarinic subtypes.
Discussion
In the present study, we investigated the role of β-arrestin
in agonist-promoted internalization of the M2 mAChR,
which has previously been reported to be β-arrestin inde-
pendent. In previous studies, heterologous over-expres-
sion of wild type and dominant-negative forms of
arrestins was used to assess the function of these proteins
Expression of β-arrestin 1 or 2 rescued agonist-promoted internalization of M2 mAChRs in MEF KO1/2 cellsFigure 3
Expression of β-arrestin 1 or 2 rescued agonist-promoted internalization of M2 mAChRs in MEF KO1/2 cells. 
Approximately 24 h following co-transfection with constructs encoding M2 mAChRs and β-arrestins, cells were stimulated with 
1 mM carbachol for 1 h. A.) Agonist-promoted internalization was determined as described in Methods. Data are presented as 
the mean ± standard deviation of 5 independent experiments consisting of 8–11 determinants. B.) A representative immunob-
lot of FLAG-tagged β-arrestin and internal protein control β-actin is shown. Lanes consisted of: non-transfected MEF KO1/2 
(1), MEF KO1/2 expressing β-arrestin1 (2), MEF KO1/2 expressing β-arrestin 2 (3), and MEF KO1/2 expressing β-arrestin 1 
and 2 (4). Western blot shown is a representative of at least 3 independent experiments.Page 6 of 15
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Stimulation of M2 mAChRs leads to stable co-localization of β-arrestin 2-GFP at intracellular sitesFigure 4
Stimulation of M2 mAChRs leads to stable co-localization of β-arrestin 2-GFP at intracellular sites. MEF wild type 
or KO1/2 cells were transiently co-transfected with the human FLAG-tagged M2 mAChR and β-arrestin 2-GFP constructs. Fol-
lowing 30 minutes of 1 mM carbachol stimulation, cells were fixed and processed for indirect immunofluorescence as 
described in the Methods. Localization of β-arrestin 2-GFP and M2 mAChR was visualized by confocal microscopy. Confocal 
images are representative of three independent experiments.
Journal of Molecular Signaling 2006, 1:7 http://www.jmolecularsignaling.com/content/1/1/7
Page 8 of 15
(page number not for citation purposes)
Agonist-promoted internalized FLAG-tagged M2 mAChRs exhibit overlap with β-arrestin 2-GFP at intracellular sites in various cell linesFigur  5
Agonist-promoted internalized FLAG-tagged M2 mAChRs exhibit overlap with β-arrestin 2-GFP at intracellu-
lar sites in various cell lines. Cells were transiently transfected with FLAG-tagged M2 mAChR and β-arrestin 2-GFP and 
treated with 1 mM carbachol for 30 min at 37°C. Co-localization of β-arrestin 2-GFP with internalized M2 mAChRs occurred 
in HeLa, COS-7 and rat aortic smooth muscle cells (RASMCs). Arrows indicate overlap between β-arrestin 2-GFP and M2 
mAChRs in intracellular compartments. Confocal images are representative of three independent experiments.
Journal of Molecular Signaling 2006, 1:7 http://www.jmolecularsignaling.com/content/1/1/7[22,32]. Unfortunately, such studies are difficult to inter-
pret because of the complications associated with endog-
enous proteins. In an attempt to alleviate these
complications, we utilized mouse embryonic fibroblasts
(MEFs) derived from β-arrestin knockouts in which
endogenously expressed β-arrestin 1 and 2 have been
genetically eliminated [26]. These cells provide us a
unique opportunity to assess whether β-arrestin proteins
are involved in the process of agonist-promoted internal-
ization of M2 mAChRs. Herein, we show that agonist-pro-
moted endocytosis of the M2 mAChR is β-arrestin- and
clathrin-dependent.
Expression of β-arrestin mutants deficient in clathrin and/or AP-2 binding interaction partially supports agonist-promoted inte nalizati n of M2 mAChRs in MEF K/O1/2, w ile expression of truncated carboxyl-terminal region of β-arrestin 1 (319–418) completely blocked agonist promoted M2 mAChR internalization i  MEFwt cellsFigure 6
Expression of β-arrestin mutants deficient in clathrin and/or AP-2 binding interaction partially supports ago-
nist-promoted internalization of M2 mAChRs in MEF K/O1/2, while expression of truncated carboxyl-terminal 
region of β-arrestin 1 (319–418) completely blocked agonist promoted M2 mAChR internalization in MEFwt 
cells. A.) Approximately 24 hr following co-transfection with FLAG-M2 mAChR and β-arrestin 2 clathrin (ΔLIELD), AP-2 
(F391A), or clathrin and AP-2 (ΔLIELD/F391A) mutants, MEF KO1/2 cells were stimulated with 1 mM carbachol for 1 h and 
agonist-promoted internalization was determined as described in Methods. Data are presented as mean ± standard deviation 
from 4 independent experiments consisting of 8–11 determinants. B.) Approximately 24 hr following transfection with the β-
arrestin 1 C-terminal domain (319–418), MEF wild type cells were stimulated with 1 mM carbachol for 1 h and agonist-pro-
moted internalization of receptor was determined as described in Methods. Data are presented as the mean ± standard error 
from 3 separate experiments with each experiment consisting of 8 to 11 independent determinations. Statistical test was per-
formed using ANOVA with the post hoc Bonferroni/Dunn test (asterisk indicates * p < 0.001).Page 9 of 15
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Addition of agonist leads to the redistribution of β-arrestin 1-GFP to early endosomal structures in the cytosolFigure 7
Addition of agonist leads to the redistribution of β-arrestin 1-GFP to early endosomal structures in the cytosol. 
HeLa cells were transiently transfected with human FLAG-tagged M2 mAChR and β-arrestin 1-GFP and treated with 1 mM car-
bachol for 30 minutes. Cells were processed for confocal microscopy. β-arrestin 1-GFP complexes localized to the early endo-
some as shown by colocalization with markers of that compartment (EEA-1 and TfnR). Arrows indicate signficant overlap 
between TfnR or EEA-1 with β-arrestin 1-GFP. Confocal images are representative of three independent experiments.
Journal of Molecular Signaling 2006, 1:7 http://www.jmolecularsignaling.com/content/1/1/7Both β-arrestin 1 and 2 isoforms were reported to form
high affinity complexes with the agonist-activated M2
mAChR [33], suggesting that either isoform is capable of
mediating agonist-promoted internalization of the recep-
tor. In corroboration with these findings, we observed no
selectivity between β-arrestin isoforms in mediating ago-
nist-promoted internalization of M2 mAChRs. Perhaps,
this lack of selectivity between β-arrestin 1 and 2 may
explain why using over-expression of a single mutant
form of β-arrestin fails to completely block the agonist-
promoted internalization of M2 mAChRs. Interestingly,
our studies further revealed that β-arrestin remained sta-
bly associated with the M2 mAChR in juxtanuclear endo-
somes for prolonged periods of time following agonist
exposure. Given that MEF cells do not endogenously
express mAChRs, we compared our observations in a
physiologically relevant cell line (RASMCs) and two
model cell lines (HeLa and COS-7). Similar findings were
also observed in these cells. Closer examination of β-arres-
tin post-endocytic trafficking revealed that M2 mAChR
stimulation led to arrestin redistribution into Tfn and
EEA-1 positive compartments, markers of the early endo-
some. In accordance with our findings, Delaney et al. have
reported that stimulated M2 mAChRs internalize in a
manner that quickly merges with clathrin-derived early
endosomes [25].
M2 mAChRs follow the general pattern utilized by most
GPCRs in that they are internalized via a β-arrestin-
dependent mechanism. Additionally, the stable binding
of β-arrestin with activated M2 mAChRs within microcom-
partments follows the paradigm of other Class B GPCRs.
Implications of these findings are that β-arrestin may dic-
tate the intracellular trafficking and/or signalling of the
M2 mAchRs. Since β-arrestin has emerged as a versatile
adaptor and scaffolding protein, its role in regulating M2
mAChR-dependent cellular activity may be significant. It
has been shown that β-arrestins interact with trafficking
machinery such as Arf6, RhoA, NSF, and a variety of sig-
nalling proteins such as ASK1, JNK3, and ERK1/2 [34].
Stable β-arrestin/receptor complexes, as exhibited by
Class B receptors, appear to redirect signalling complexes
to the cytoplasm thereby activating cytoplasmic targets
while preventing ERK translocation to the nucleus
[15,16,35]. The physiological role of this process may be
to participate in actin cytoskeleton reorganization and
chemotaxis [18,36]. With regard to intracellular traffick-
ing, patterns of β-arrestin binding to activate receptors
appear to modulate receptor recycling and/or degradation
[37]. Class A receptors are typically resensitized and sub-
sequently recycled while Class B receptors undergo slow
recycling and/or down-regulation. M2 mAChRs have been
shown to undergo slow recycling back to the plasma
membrane upon agonist removal [38]. What role or roles
β-arrestin plays in M2 mAChR recycling and/or degrada-
tion is currently unknown. The functional consequence of
stable β-arrestin/M2 mAChR complexes remains to be
determined.
Previous studies have suggested that M2 mAChR internal-
ization does not proceed through a β-arrestin/clathrin
mediated pathway [22,23,28]. For example, Delaney and
co-workers [25] previously reported that M2 mAChRs
internalized by a clathrin-independent pathway based
upon the use of a dominant-negative K44A dynamin-1
mutant. However, expression of a N-terminal deletion
dynamin-1 mutant N272 that lacks the complete GTP-
binding domain, unlike K44A dynamin, strongly inhib-
ited agonist-promoted M2 mAChR internalization [39].
Therefore, we conducted experiments with arrestin
mutants that were selectively deficient in interaction with
clathrin, AP-2, or both clathrin and AP-2, to determine
whether agonist mediated internalization of M2 mAChRs
was clathrin-dependent. Expression of arrestin mutants
defective in interaction with either clathrin (β-arrestin 2-
ΔLIELD) or AP-2 (β-arrestin 2-F391A) failed to antagonize
M2 mAChR internalization. Moreover, over-expression of
a dominant-negative arrestin mutant that was defective in
interaction with both clathrin and AP-2 only modestly
antagonized M2 mAChR internalization in MEF KO1/2
cells. Thus, it is reasonable to conclude that these data cor-
roborate previous studies indicating that M2 mAChR
internalization is clathrin-independent. However, Santini
and co-workers [30] have reported that arrestin mutants
with impaired binding to clathrin or AP-2 were still capa-
ble of displaying recruitment of β2AR to clathrin-coated
pits, albeit to a reduced degree. Therefore, it may be pre-
mature to conclude that M2 mAChR internalization is β-
arrestin-dependent but clathrin/AP-2-independent.
Expression of the truncated carboxy-terminal region of β-
arrestin 1, which contained the clathrin interaction site,
has been shown to completely abrogate β2AR mediated
clustering of clathrin coated pits [31]. Exogenous expres-
sion of this mutant completely block agonist-promoted
internalization of M2 mAChRs in wild type MEFs. Collec-
tively, these results indicate that agonist-promoted inter-
nalization of M2 mAChRs is β-arrestin-dependent and
most likely clathrin/AP-2-dependent. However, we can-
not rule out that the C-terminal region of arrestin 1 is
interacting with another factor, independent from clath-
rin/AP-2 that may be responsible for mediating internali-
zation of the M2 mAChR. Indeed previous studies have
shown that the Arf6 GTPase regulates agonist-promoted
endocytosis of the M2 mAChR [24,25]. It has been shown
that β2AR stimulation leads to activation of Arf6 GTPase,
which facilitates receptor endocytosis [40]. It is feasible
that sequestration of M2 mAChR requires activation of
Arf6 GTPase by a β-arrestin-mediated pathway, which
may be an important component of agonist-promoted
internalization of the M2 mAChR. This would corroboratePage 11 of 15
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GTPase in mediating agonist-promoted M2 mAChR inter-
nalization [24].
The differential trafficking of β-arrestin with mAChRs to
endosomes appears to be subtype specific. There are five
muscarinic subtypes termed M1mAChR- M5 mAChR. M1,
M3, and M5 mAChRs couple to Gq proteins and activate
phospholipase C whereas M2 mAChR and M4 mAChR
couple to Gi/o to inhibit adenylyl cyclase and activate K+
channels [1,2]. As shown in Figure 8, stimulated mus-
carinic subtypes aside from M2 mAChRs are sequestered
into endocytic vesicles that are devoid of β-arrestin. It has
been shown that M1 mAChR, M3 mAChR, and M4 mAChR
require β-arrestin in mediating agonist-promoted inter-
nalization [23] so we do not rule out the possibility that
arrestin is recruited to the plasma membrane following
stimulation and then rapidly disassociates from the recep-
tor. It is possible that carbachol may induce receptor con-
formations that may not promote stable β-arrestin
associations with the other mAChR subtypes. However,
sequence alignment of the M2 and M4 mAChR (using the
T-coffee program) revealed that the subtypes exhibit high
sequence similarities; interestingly, the sequence differ-
ences lie in the third intracellular loop, specifically at res-
idues 293–313 within the M2 mAChR. As described by
Pals-Rylaarsdam and others, a cluster of serine and threo-
nine sites at positions 307–311 undergo agonist pro-
moted phosphorylation, which is necessary and sufficient
for β-arrestin interaction [6]. This site may be important
for designating stable interactions with β-arrestin. M2
mAChR sequences downstream from this site at 348–368
also differ significantly from the M4 mAChR suggesting
that an additional motif may be involved.
Conclusion
In summary, the data presented in this study demonstrate
that the agonist-promoted endocytosis of the M2 mAChR
subtype occurs via an arrestin dependent pathway in MEF
cells. Exogenously expressed β-arrestin proteins remained
stably associated with the M2 mAChR upon entry into
early endosomal compartments. The lack of stable β-arres-
tin interaction with other mAChR subtypes suggests a




[3H]-N-methylscopolamine (NMS) (81–84 Ci/mmol)
was purchased from Amersham Corp. (Buckinghamshire,
England). Dulbecco's Modified Eagle's Medium (DMEM),
F-10, penicillin/streptomycin, fetal bovine serum, restric-
tion enzymes and LipofectAMINE 2000 were purchased
from Invitrogen (Carlsbad, CA) EX-GEN was purchased
from Fermentas (Hanover, MD). The anti-FLAG M2 mon-
oclonal antibody and mouse anti-M1 FLAG antibody
were purchased from Sigma-Aldrich (St. Louis, MO);
mouse antibodies against β-arrestin 1 and 2 were pur-
chased from Santa Cruz (Santa Cruz, CA). The anti-HA.11
monoclonal antibody was purchased from Covance
Research Product (Berkley, California) Secondary HRP-
conjugated antibodies were purchased from Jackson
Immunoresearch Laboratories Inc. (West Grove, PA). Car-
bachol, atropine and all other reagents were purchased
from Sigma-Aldrich. Dr. Neil Nathanson (University of
Washington) kindly provided the construct expressing the
porcine FLAG-tagged M2 mAChR [32]. HA-tagged M1, M3,
M4, and M5 mAChRs were purchased from UMR cDNA
Resource Center (University of Missouri). Arrestin
mutants, β-arrestin 2-ΔLIELD, β-arrestin 2-F391A, β-arres-
tin 2 ΔLIELD/F391A, and truncated carboxyl-terminal
region of β-arrestin 1 (319–418) were kindly provided by
Dr. Jeffrey Benovic (Thomas Jefferson University) [30,31].
The MEF wild type, β-arrestin 1 and 2 single knockouts, β-
arrestin 1 and 2 double knockout cells, and constructs for
FLAG-tagged β-arrestin 1 and 2 were kindly provided by
Dr. Robert Lefkowitz (Duke University Medical Center)
[26]. Constructs encoding β-arrestin 2-GFP and β-arrestin
1-GFP were generous gifts from Dr. Stefano Marullo and
have been previously described [41].
Cell Culture and Transient Transfection
HeLa, MEF wild-type, MEF single and double β-arrestin
knockout, RASMCs, and COS-7 cells were maintained in
DMEM supplemented with 10% fetal bovine serum
(FBS), 100 I.U./ml penicillin, and 100 μg/ml streptomy-
cin at 37°C with 5% CO2. For immunocytochemistry,
HeLa cells were grown on glass coverslips at a density of
120,000 cells/well in six-well dishes and transfected with
EX-GEN or LipofectAMINE 2000 according to the manu-
facturer's protocol using 1 μg of DNA/well. For ligand
binding assays, MEF cells were plated at 80,000 cells/well
in 24 well plates and transfected with EX-GEN or Lipo-
fectAMINE 2000 according to the manufacturer's protocol
using 1 μg of DNA/well.
Radioligand Binding Assay
Receptor internalization was determined by measuring
the binding of the membrane impermeable muscarinic
antagonist [3H]-N-methylscopolamine ([3H]-NMS) to
intact cells as previously described [42]. Briefly, 24–42 h
after transfection, MEF cells cultured in 24-well plates
were treated or not treated with 1 mM carbachol for 60
min at 37°C. Cultures were washed twice with 1 ml of ice-
cold PBS, and labelled with 720 fmol of [3H]-NMS in 1 ml
PBS for 4 h at 4°C. Non-specific binding was determined
as the bound radioactivity in the presence of 1 μM atro-
pine. Labelled cells were washed two times with 1 ml of
ice-cold PBS, solubilized in 0.5 ml of 1% Triton X-100 and
combined with 3.5 ml of scintillation fluid followed byPage 12 of 15
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Internalized M2 mAChRs exhibit a differential affinity for β-arrestin 2-GFP compared to other muscarinic subtypesFigure 8
Internalized M2 mAChRs exhibit a differential affinity for β-arrestin 2-GFP compared to other muscarinic sub-
types. HeLa cells were transiently co-transfected with plasmids encoding β-arrestin 2-GFP and either HA-tagged M1, M3, M4, 
M5 mAChR or FLAG-tagged M2 mAChR. Cells were untreated or treated with 1 mM carbachol for 0 min or 30 min. Grayscale 
image indicates β-arrestin 2-GFP localization while the upper right inset indicates immunostaining of the mAChR in a small sec-
tion of the cell (outline). Arrows indicate overlap between internalized M2 mAChRs and β-arrestin 2-GFP. Overlay represents 
co-immunostaining of mAChR (red) and β-arrestin 2-GFP expression (green) and their colocalization (yellow).
Journal of Molecular Signaling 2006, 1:7 http://www.jmolecularsignaling.com/content/1/1/7measurement of radioactivity. Receptor internalization is
defined as percent of surface M2 mAChRs not accessible to
[3H]-NMS at each time relative to non-carbachol-treated
cells.
Immunoblotting
Western blot analysis was performed on cells cultured in
6-well plates. The cells were solubilized in 0.5 ml of lysis
buffer containing: 50 mM HEPES (pH 7.5), 0.5% (v/v)
Nonidet P-40, 250 mM NaCl, 2 mM EDTA, 10% (v/v)
glycerol, 1 mM sodium orthovanadate, 1 mM sodium flu-
oride and 1 μg/ml of protease inhibitors leupeptin, apro-
tinin, pepstatin A, and 100 μM benzamidine. The protein
concentration was determined using the Bradford assay
method. Fifty μg of cell lysates were subjected to 4–20%
SDS-PAGE. After transfer, the nitrocellulose membrane
was blocked and then probed with anti-FLAG mono-
clonal antibody. Immunoreactive bands were visualized
by enhanced chemiluminescence after adding HRP-conju-
gated anti-mouse antibody. After stripping with 0.1 M gly-
cine (pH 2.5), the membrane was re-probed with anti-β-
actin using a detection kit from Oncogene (Cambridge,
MA).
Indirect Immunofluorescence
24 h following transfection, cells were treated as described
in the figure legends, fixed in 4% formaldehyde in PBS for
5 minutes, and rinsed with 10% fetal bovine serum and
0.02% azide in PBS (PBS/serum). Fixed cells were incu-
bated with primary antibodies diluted in PBS/serum con-
taining 0.2% saponin for 45 minutes, and then washed
with PBS/serum (3 × 5 min.). The cells were then incu-
bated with fluorescently labelled secondary antibodies in
PBS-serum and 0.2% saponin for 45 minutes, washed
with PBS/serum (3 × 5 min.) and once with PBS, and
mounted on glass slides. Images were acquired using a
Zeiss LSM 510 scanning confocal microscope or an Olym-
pus BX40 epifluorescence microscope equipped with a
60× Plan pro lens, and photomicrographs were prepared
using an Olympus MagnaFire SP digital camera (Olympus
America, Inc.). All images were processed with Adobe
Photoshop 7.0 software.
RNA Isolation and RT-PCR
Total cellular RNA from MEF cells, cortex and cerebellum
of 2–3 week old Sprague Dawley rat pups was isolated
using TriZol according to the manufacturer's instructions.
A 50 μl reaction solution containing 1 μg total RNA was
reverse-transcribed, and PCR was performed using gene-
specific primers and the Qiagen One-step RT-PCR kit.
Gene specific primers and amplification reactions were as
follows: Rat M1 mAChR (175 bp amplified product):
CCTCTGCTGCCGCTGTTG (sense) and GGTGGGT-
GCCTGTGCTTCA (antisense); Rat M2 mAChR (686 bp
amplified product): CACGAAACCTC TGA CCTACCC
(sense) and TCTGACCCGACGACCCAACTA (antisense);
Rat M4 mAChR (587 bp amplified product): TGGGTCTT-
GTCCTTTGT GCTC (sense) and TTCATTGCCTGTCT-
GCTT TGTTA (antisense); Rat β-actin (764 bp amplified
product): TTGTAACCAACTGGGACGATATGG (sense)
and GATCTT GATCT TCATGGT GCTAGG (antisense).
Cycling parameters were 30 minutes at 50°C for reverse
transcription followed by 1 minute 95°C hot start fol-
lowed by 28 cycles at 95°C for 1 minute, 62°C for 1
minute, and 72°C for 45 seconds and a final cycle at 72°C
for 7 minutes.
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